Moderna, Merck, and the National Cancer Institute announced successful trial results for a combined cancer vaccine and immunotherapy program.

The entities involved

• Moderna →

  American biotechnology company

  • Moderna and Merck announced the successful outcome of their Phase 3 combined treatment trials involving a new cancer vaccine and Keytruda.Sun 12:39
  • Merck and Moderna funded an Australian-led clinical trial involving the University of Sydney.Sat 22:35
• National Cancer Institute →

  public hospital in Milan dedicated to cancer care

  Nothing else this week.

• Merck →

  public company in Indonesia

  • AbbVie, Eli Lilly, and Merck are broadening their therapeutic reach.Sun 10:21
  • Eli Lilly and Merck are combining therapies in clinical trials.Sun 10:21

Related events

• Moderna and Merck announced a partnership on their mRNA cancer vaccine trial, leading to analyst rating hikes.Aug 25
• Moderna presented vaccine results at the ESMO meeting in Madrid, with RBC Capital Markets covering the company.Fri 10:55
• Moderna and Merck are seeking FDA review for a novel cancer treatment, having co-led a Phase 3 mRNA vaccine trial.Aug 19
• Merck participates in a cancer vaccine study, with a researcher based at MD Anderson Cancer Center in Houston.Fri 04:40